This company seems to have been delisted
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Reason: Acquired by Kyowa Kirin
Last recorded trade on: March 20, 2024
Source: https://www.ns-healthcare.com/news/kyowa-kirin-wraps-up-acquisition-of-orchard-therapeutics/
Orchard Therapeutics
ORTX
£12.24
Share price
0.00%
Change (1 day)
222.85%
Change (1 year)
Orchard Therapeutics (ORTX) - Total assets
Total assets on the balance sheet as of September 2023 : £0.14 Billion
According to Orchard Therapeutics 's latest financial reports the company's total assets are £0.14 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Orchard Therapeutics - Total assets on balance sheet (from 2017 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | £0.18 B | -24.24% |
| 2021-12-31 | £0.23 B | 15.89% |
| 2020-12-31 | £0.20 B | -32.31% |
| 2019-12-31 | £0.30 B | 5.59% |
| 2018-12-31 | £0.28 B | 300.57% |
| 2017-12-31 | £71.98 M | 1973.97% |
| 2016-12-31 | £3.47 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | £0.91 B | 517.41% | Jersey |
 Novavax NVAX | £0.94 B | 539.25% | 🇺🇸 USA |
 Organovo ONVO | £10.73 M | -92.76% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | £0.14 B | 0.00% | 🇬🇧 UK |